SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-001908
Filing Date
2015-03-10
Accepted
2015-03-10 16:32:50
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223469z10-k.htm 10-K 1402273
2 EX-23.1 a2223469zex-23_1.htm EX-23.1 4032
3 EX-31.1 a2223469zex-31_1.htm EX-31.1 7874
4 EX-32.1 a2223469zex-32_1.htm EX-32.1 4024
11 G508519.JPG g508519.jpg GRAPHIC 42692
  Complete submission text file 0001047469-15-001908.txt   10831817

Data Files

Seq Description Document Type Size
5 EX-101.INS espr-20141231.xml EX-101.INS 1860624
6 EX-101.SCH espr-20141231.xsd EX-101.SCH 49509
7 EX-101.CAL espr-20141231_cal.xml EX-101.CAL 57700
8 EX-101.LAB espr-20141231_lab.xml EX-101.LAB 516910
9 EX-101.PRE espr-20141231_pre.xml EX-101.PRE 393361
10 EX-101.DEF espr-20141231_def.xml EX-101.DEF 202715
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 15689534
SIC: 2834 Pharmaceutical Preparations